Sail Biomedicines
Somerville
About Sail Biomedicines
Sail Biomedicines is a flagship pioneering company that is developing tomorrow's medicines today using life's language. Sail's platform combines first-in-class translatable circular RNA technology (Endless RNATM or eRNA) with unique programmable nanoparticles based on natural components to thoroughly program medications for the first time.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Last round: Grant (Jan 2024)
- Website: sail.bio
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/sail-biomedicines-184883 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.